# Biomarin Pharmaceutical Inc: Form 8-K/A, filed Jul 13, 2026

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: 8-K/A
- Filed: 2026-07-13
- Accepted by EDGAR: Jul 13, 2026, 16:06 ET
- Period: 2026-04-27
- Accession: 0001048477-26-000011
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000104847726000011/bmrn-20260427.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000104847726000011/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000104847726000011/bmrn-20260427.htm

Filed Jul 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001048477-26-000011. Last ingested by Listed: Nov 4, 2026, 16:43 ET. No prices; not investment advice.